Genomic Health, Inc. (GHDX) Tops Q4 EPS by 3c, Guides FY13
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Income tax expense: 464K
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Income tax expense: 464K
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Genomic Health, Inc. (NASDAQ: GHDX) reported Q4 EPS of $0.06, $0.03 better than the analyst estimate of $0.03. Revenue for the quarter came in at $60.4 million versus the consensus estimate of $58.9 million.
Genomic Health, Inc. sees FY2013 revenue of $258-266 million, versus the consensus of $262.40 million.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Genomic Health, Inc. sees FY2013 revenue of $258-266 million, versus the consensus of $262.40 million.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
- YETI Holdings, Inc. (YETI) Tops Q2 EPS by 12c
- Dynatrace to buy Arize in $915M cash-and-stock deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
